Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
NIH R21 awards for innovative secondary analysis of existing social science, behavioral, administrative, and neuroimaging datasets on substance use, HIV prevention, and related health service use for eligible institutions and organizations.
⚑ R21; Clinical Trial Not Allowed · uses existing/extant datasets only; no new primary data collection · foreign organizations are eligible · award ceiling listed as $0 in the notice
This is substance-use etiology, HIV, and clinical/health-services research, which is outside IPPRA’s core public-opinion, risk, weather, energy, and education policy lines. The team’s survey and administrative-data expertise could help methodologically, but there is no member whose published program centers on addiction or biomedical behavioral health.
JUDGED AGAINST THE ROSTER'S PUBLICATION DOSSIER · GPT-5.4-MINI · 2026-07-07
Unit fits — one characterization, each unit's own rules
| IPPRA | 100 strong | portfolio topic: public_health (primary); signature methods: policy analysis; social/behavioral work is central; funds applied research |
| Physical Sciences & Engineering (demo) | 80 strong | technical depth: substantial; funds applied research |
| Tom Love Innovation Hub | 25 weak | funds applied research; deep-tech content |
Description
The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Apply
View on Grants.gov → CONTACT: National Institutes of Health <grantsinfo@nih.gov>
Proposal brief SEE AN EXAMPLE →
A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.
Proposal shell · National Institutes of Health conventions SEE AN NIH EXAMPLE →
Funder-faithful document skeletons — National Institutes of Health's document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.